Updated hourlyHourly refreshWed, Sep 23, 2026
Press Release Database
Recent press releases, indexed by topic.
Healthcare
(PR-inside.com) Collaboration Brings ESNR Endorsement to Cercare Medical's Flagship Perfusion Imaging Event, Taking Place 29-30 April 2027 in Milan, Italy. AARHUS, DENMARK / ACCESS Newswire / September 16, 2026 / Cercare Medical, a leader in advanced neuroimaging software, today announced an educational collaboration with the European Society of Neuroradiology (ESNR) in support of Perfusion Summit 2027, the company's flagship international meeting for perfusion imaging professionals. The Summit will take place 29-30 April 2027 at the Crowne Plaza Linate in Milan, Italy. Now entering its fourth year, Perfusion Summit has grown into a global meeting point for radiologists, neuroradiologists, and imaging scientists working with ..
Sep 16 · 12:20·PR-Inside
Healthcare
Veteran Physician Leader to Advance Clinical Strategy, Physician Engagement and Value-Based Care Initiatives
Sep 16 · 12:00·Newswire.com
Finance · Healthcare
Acquisition brings Alaris' staff-to-child ratio tracking, meal program compliance, and state licensing support to nonprofit, community and recreation centers, and health club childcare programs BIRMINGHAM, Ala., Sept. 16, 2026 /PRNewswire/ -- Daxko, the leading integrated software and...
Sep 16 · 12:00·mlpr-prnewswire-wire
Finance · Healthcare
CLEVELAND, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing genetic medicines for serious diseases with high unmet need, today announced the activation of University of Florida Health (UF Health) in Gainesville, Florida, as the eighth Qualified Treatment Center (QTC) for the administration of ZEVASKYN (prademagene zamikeracel) gene-modified cellular sheets. ZEVASKYN is the first and only autologous gene-modified cellular sheets for the treatment of wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB).
Sep 16 · 11:30·GlobeNewswire
Finance · SaaS
HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company”), today announces the appointment of Samantha Fowlkes as Vice President Head of Commercial Sales. Samantha will lead the commercial expansion of CNSide®, strengthening relationships across the oncology and pathology communities, and accelerate adoption of the CNSide platform by physicians and health systems.
Sep 16 · 11:30·GlobeNewswire
Finance · SaaS
Combination adds new intelligent clinical data intake capabilities to MRO's integrated platform for healthcare organizations NORRISTOWN, Pa., Sept. 16, 2026 /PRNewswire/ -- MRO, the leading clinical data management platform, announces the acquisition of Vyne Medical, a provider of data...
Sep 16 · 11:30·PR Newswire
Healthcare
Teva Pharmaceuticals former SVP and global innovative medicine R&D leader joins Remepy's executive management team as the Company prepares to commence Phase III of its Hybrid DrugTM for Parkinson's disease and expand its Hybrid Drug pipeline NEW YORK, September 16, 2026 /PRNewswire/ --...
Sep 16 · 11:30·PR Newswire
Finance · Healthcare
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 16, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Fractyl Health, Inc. (NASDAQ:GUTS) securities. If you suffered a loss on your Fractyl Health, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Fractyl Health, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
Sep 16 · 11:20·PR-Inside
Healthcare
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESToronto, Ontario--(Newsfile Corp. - September 16, 2026) - Altrova Health Inc. (CSE: ROVA) (OTCQB: ATVHF) (FSE: WF8) ("Altrova Health" or the "Company") announces that it proposes to enter into debt settlement agreements with three consultants to settle aggregate indebtedness of C$215,000 through the issuance of an aggregate of 3,583,333 common shares of the Company ("Common Shares") at a deemed...
Sep 16 · 11:07·mlpr-newsfile
Finance · Healthcare
(PR-inside.com) Transaction expected to create a Nasdaq-listed, multi-indication clinical-stage company focused on targeting neutrophil extracellular traps (NETs), a driver of disease across critical care, autoimmune disease, transplantation and oncology Union of two companies brings together Santersus' NucleoCapture® technology, designed to physically remove NETs from circulation, with Xenetic's DNase technology, designed to enzymatically degrade NETs in tissue Joint pipeline includes four first-in-class programs, including pivotal-stage programs in sepsis and systemic lupus erythematosus (SLE), both of which have received FDA Breakthrough Device Designation Companies to host Business Update Conference Call and Webcast Today, Wednesday, September 16th at 8:30 AM ET FRAMINGHAM, MA / ACCESS
Sep 16 · 11:02·PR-Inside
Finance · Healthcare
SAN DIEGO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disease, today announced that four abstracts from its off-the-shelf CAR T-cell programs have been selected for presentation at the American College of Rheumatology (ACR) Convergence 2026, being held November 6-11 in Orlando, Florida.
Sep 16 · 11:00·GlobeNewswire
Healthcare
Die erste umfassende weltweite Studie der International League of Dermatological Societies (ILDS) und L'Oréal Dermatological Beauty erstreckt sich über 158 Länder und umfasst 97 % der Weltbevölkerung. Zusammenfassung: Die Studie „Global Access to Skin Health Observatory Study", die in der...
Sep 16 · 10:39·PR Newswire